secwatch.observer — SEC 8-K summary
======================================

Issuer:     EXAGEN INC. (XGN)
CIK:        0001274737
Form:       8-K
Filed at:   2024-08-02T23:59:59+00:00
Accession:  0001274737-24-000071
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Exagen appoints Jeffrey Black as CFO; Kamal Adawi steps down
------------------------------------------------------------

- Jeffrey G. Black named CFO effective Sept 1, 2024; replaces Kamal Adawi.
- John Aballi serves as interim CFO from July 31 until Black's start.
- Black receives $460K base salary, $125K signing bonus, and up to 225K RSUs.
- Black previously CFO at Standard BioTools, Apollo Endosurgery, and Alphatec Spine.
- Adawi entitled to severance as Tier 2 participant under company's severance plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1274737/000127473724000071/0001274737-24-000071-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1274737/000127473724000071/exdx-20240731.htm
  HTML page:      https://secwatch.observer/filing/0001274737-24-000071

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer